Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Environmental Neurology has become a hot topic.

Reis J, Béjot Y, Giroud M, Spencer P.

Rev Neurol (Paris). 2019 Oct 11. pii: S0035-3787(19)30860-4. doi: 10.1016/j.neurol.2019.09.006. [Epub ahead of print] No abstract available.

PMID:
31611008
2.

Influence of Pre-Existing Mild Cognitive Impairment and Dementia on Post-Stroke Mortality. The Dijon Stroke Registry.

Graber M, Garnier L, Mohr S, Delpont B, Blanc-Labarre C, Vergely C, Giroud M, Béjot Y.

Neuroepidemiology. 2019 Oct 8:1-8. doi: 10.1159/000497614. [Epub ahead of print]

3.

Association Between Fatigue and Cognitive Impairment at 6 Months in Patients With Ischemic Stroke Treated With Acute Revascularization Therapy.

Graber M, Garnier L, Duloquin G, Mohr S, Guillemin S, Ramaget O, Piver A, Tainturier C, Bret-Legrand C, Delpont B, Blanc-Labarre C, Guéniat J, Hervieu-Bègue M, Osseby GV, Giroud M, Béjot Y.

Front Neurol. 2019 Aug 28;10:931. doi: 10.3389/fneur.2019.00931. eCollection 2019.

4.

Assessment of Somatosensory Reorganization by Functional Magnetic Resonance Imaging After Hand Replantation.

Guillier D, Moris V, Daubail B, Rizzi P, Tchurukdichian A, Baudoin N, Bejot Y, Zwetyenga N, Jacquin-Piques A.

Ann Plast Surg. 2019 Oct;83(4):468-474. doi: 10.1097/SAP.0000000000001946.

PMID:
31524745
5.

Intravenous thrombolysis for suspected ischemic stroke with seizure at onset.

Polymeris AA, Curtze S, Erdur H, Hametner C, Heldner MR, Groot AE, Zini A, Béjot Y, Dietrich A, Martinez-Majander N, von Rennenberg R, Gumbinger C, Schaedelin S, De Marchis GM, Thilemann S, Traenka C, Lyrer PA, Bonati LH, Wegener S, Ringleb PA, Tatlisumak T, Nolte CH, Scheitz JF, Arnold M, Strbian D, Nederkoorn PJ, Gensicke H, Engelter ST; TRISP Collaborators.

Ann Neurol. 2019 Nov;86(5):770-779. doi: 10.1002/ana.25582. Epub 2019 Sep 9.

PMID:
31435960
6.

Availability of secondary prevention services after stroke in Europe: An ESO/SAFE survey of national scientific societies and stroke experts.

Webb A, Heldner MR, Aguiar de Sousa D, Sandset EC, Randall G, Bejot Y, van der Worp B, Caso V, Fischer U; ESO-SAFE Secondary Prevention Survey Steering Group.

Eur Stroke J. 2019 Jun;4(2):110-118. doi: 10.1177/2396987318816136. Epub 2018 Nov 27.

7.

Growth Differentiation Factor-15 (GDF-15) Is Associated With Mortality in Ischemic Stroke Patients Treated With Acute Revascularization Therapy.

Brenière C, Méloux A, Pédard M, Marie C, Thouant P, Vergely C, Béjot Y.

Front Neurol. 2019 Jun 14;10:611. doi: 10.3389/fneur.2019.00611. eCollection 2019.

8.

Assessment of Somatosensory Reorganization by Functional Magnetic Resonance Imaging After Hand Replantation.

Guillier D, Moris V, Daubail B, Rizzi P, Tchurukdichian A, Baudoin N, Bejot Y, Zwetyenga N, Jacquin-Piques A.

Ann Plast Surg. 2019 Jun 25. doi: 10.1097/SAP.0000000000001946. [Epub ahead of print]

PMID:
31246670
9.

Targeting blood pressure for stroke prevention: current evidence and unanswered questions.

Béjot Y.

J Neurol. 2019 Jun 26. doi: 10.1007/s00415-019-09443-5. [Epub ahead of print] Review.

PMID:
31243539
10.

Air pollution and stroke. A new modifiable risk factor is in the air.

Graber M, Mohr S, Baptiste L, Duloquin G, Blanc-Labarre C, Mariet AS, Giroud M, Béjot Y.

Rev Neurol (Paris). 2019 May 29. pii: S0035-3787(18)30976-7. doi: 10.1016/j.neurol.2019.03.003. [Epub ahead of print] Review.

PMID:
31153597
11.

In the here and now: Short term memory predictions are preserved in Alzheimer's disease.

Bertrand JM, Mazancieux A, Moulin CJA, Béjot Y, Rouaud O, Souchay C.

Cortex. 2019 Oct;119:158-164. doi: 10.1016/j.cortex.2019.03.027. Epub 2019 May 2.

PMID:
31132694
12.

A review of psychosocial factors and stroke: A new public health problem.

Graber M, Baptiste L, Mohr S, Blanc-Labarre C, Dupont G, Giroud M, Béjot Y.

Rev Neurol (Paris). 2019 May 24. pii: S0035-3787(19)30005-0. doi: 10.1016/j.neurol.2019.02.001. [Epub ahead of print] Review.

PMID:
31130312
13.

Determinants of Case Fatality After Hospitalization for Stroke in France 2010 to 2015.

Gabet A, Grimaud O, de Peretti C, Béjot Y, Olié V.

Stroke. 2019 Feb;50(2):305-312. doi: 10.1161/STROKEAHA.118.023495.

PMID:
30621528
14.

Impact of the Ageing Population on the Burden of Stroke: The Dijon Stroke Registry.

Béjot Y, Bailly H, Graber M, Garnier L, Laville A, Dubourget L, Mielle N, Chevalier C, Durier J, Giroud M.

Neuroepidemiology. 2019;52(1-2):78-85. doi: 10.1159/000492820. Epub 2019 Jan 2.

15.

Ageing Population: A Neurological Challenge.

Béjot Y, Yaffe K.

Neuroepidemiology. 2019;52(1-2):76-77. doi: 10.1159/000495813. Epub 2019 Jan 2. No abstract available.

16.

Sex Differences in Severity of Stroke in the INSTRUCT Study: a Meta-Analysis of Individual Participant Data.

Phan HT, Reeves MJ, Blizzard CL, Thrift AG, Cadilhac DA, Sturm J, Otahal P, Rothwell P, Bejot Y, Cabral NL, Appelros P, Kõrv J, Vibo R, Minelli C, Gall SL.

J Am Heart Assoc. 2019 Jan 8;8(1):e010235. doi: 10.1161/JAHA.118.010235.

17.

Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation.

Yiin GSC, Li L, Bejot Y, Rothwell PM.

Stroke. 2018 Nov 29:STROKEAHA118022249. doi: 10.1161/STROKEAHA.118.022249. [Epub ahead of print]

18.

Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.

GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, Parmar PG, Abajobir AA, Abate KH, Abd-Allah F, Abejie AN, Abyu GY, Ademi Z, Agarwal G, Ahmed MB, Akinyemi RO, Al-Raddadi R, Aminde LN, Amlie-Lefond C, Ansari H, Asayesh H, Asgedom SW, Atey TM, Ayele HT, Banach M, Banerjee A, Barac A, Barker-Collo SL, Bärnighausen T, Barregard L, Basu S, Bedi N, Behzadifar M, Béjot Y, Bennett DA, Bensenor IM, Berhe DF, Boneya DJ, Brainin M, Campos-Nonato IR, Caso V, Castañeda-Orjuela CA, Rivas JC, Catalá-López F, Christensen H, Criqui MH, Damasceno A, Dandona L, Dandona R, Davletov K, de Courten B, deVeber G, Dokova K, Edessa D, Endres M, Faraon EJA, Farvid MS, Fischer F, Foreman K, Forouzanfar MH, Gall SL, Gebrehiwot TT, Geleijnse JM, Gillum RF, Giroud M, Goulart AC, Gupta R, Gupta R, Hachinski V, Hamadeh RR, Hankey GJ, Hareri HA, Havmoeller R, Hay SI, Hegazy MI, Hibstu DT, James SL, Jeemon P, John D, Jonas JB, Jóźwiak J, Kalani R, Kandel A, Kasaeian A, Kengne AP, Khader YS, Khan AR, Khang YH, Khubchandani J, Kim D, Kim YJ, Kivimaki M, Kokubo Y, Kolte D, Kopec JA, Kosen S, Kravchenko M, Krishnamurthi R, Kumar GA, Lafranconi A, Lavados PM, Legesse Y, Li Y, Liang X, Lo WD, Lorkowski S, Lotufo PA, Loy CT, Mackay MT, Abd El Razek HM, Mahdavi M, Majeed A, Malekzadeh R, Malta DC, Mamun AA, Mantovani LG, Martins SCO, Mate KK, Mazidi M, Mehata S, Meier T, Melaku YA, Mendoza W, Mensah GA, Meretoja A, Mezgebe HB, Miazgowski T, Miller TR, Ibrahim NM, Mohammed S, Mokdad AH, Moosazadeh M, Moran AE, Musa KI, Negoi RI, Nguyen M, Nguyen QL, Nguyen TH, Tran TT, Nguyen TT, Anggraini Ningrum DN, Norrving B, Noubiap JJ, O’Donnell MJ, Olagunju AT, Onuma OK, Owolabi MO, Parsaeian M, Patton GC, Piradov M, Pletcher MA, Pourmalek F, Prakash V, Qorbani M, Rahman M, Rahman MA, Rai RK, Ranta A, Rawaf D, Rawaf S, Renzaho AM, Robinson SR, Sahathevan R, Sahebkar A, Salomon JA, Santalucia P, Santos IS, Sartorius B, Schutte AE, Sepanlou SG, Shafieesabet A, Shaikh MA, Shamsizadeh M, Sheth KN, Sisay M, Shin MJ, Shiue I, Silva DAS, Sobngwi E, Soljak M, Sorensen RJD, Sposato LA, Stranges S, Suliankatchi RA, Tabarés-Seisdedos R, Tanne D, Nguyen CT, Thakur JS, Thrift AG, Tirschwell DL, Topor-Madry R, Tran BX, Nguyen LT, Truelsen T, Tsilimparis N, Tyrovolas S, Ukwaja KN, Uthman OA, Varakin Y, Vasankari T, Venketasubramanian N, Vlassov VV, Wang W, Werdecker A, Wolfe CDA, Xu G, Yano Y, Yonemoto N, Yu C, Zaidi Z, El Sayed Zaki M, Zhou M, Ziaeian B, Zipkin B, Vos T, Naghavi M, Murray CJL, Roth GA.

N Engl J Med. 2018 Dec 20;379(25):2429-2437. doi: 10.1056/NEJMoa1804492.

19.

Brain-derived neurotrophic factor in peripheral blood mononuclear cells and stroke outcome.

Pedard M, Brenière C, Pernet N, Vergely C, Béjot Y, Marie C.

Exp Biol Med (Maywood). 2018 Nov 24:1535370218815612. doi: 10.1177/1535370218815612. [Epub ahead of print]

PMID:
30472884
20.

Adult moyamoya angiopathy in Bourgogne-Franche-Comté: Epidemiology, diagnosis and management.

Brandicourt P, Blanc C, Bonnet L, Béjot Y, Ricolfi F, Drouet C, Moulin T, Thines L.

Rev Neurol (Paris). 2019 Apr;175(4):247-251. doi: 10.1016/j.neurol.2018.05.004. Epub 2018 Nov 14.

PMID:
30447881
21.

Ischemic Stroke Increases Heart Vulnerability to Ischemia-Reperfusion and Alters Myocardial Cardioprotective Pathways.

Meloux A, Rigal E, Rochette L, Cottin Y, Bejot Y, Vergely C.

Stroke. 2018 Nov;49(11):2752-2760. doi: 10.1161/STROKEAHA.118.022207.

PMID:
30355197
22.

What is the evolution of stroke unit's accessibility in metropolitan France from 2009 to 2014? A trend analysis of over 600 000 patients using national hospital databases.

Istvan M, Lecoffre C, Bayat S, Béjot Y, Le Strat Y, De Peretti C, Gao F, Olié V, Grimaud O.

BMJ Open. 2018 Sep 28;8(9):e023599. doi: 10.1136/bmjopen-2018-023599.

23.

Increased ischemic stroke, acute coronary artery disease and mortality in patients with granulomatosis with polyangiitis and microscopic polyangiitis.

Mourguet M, Chauveau D, Faguer S, Ruidavets JB, Béjot Y, Ribes D, Huart A, Alric L, Balardy L, Astudillo L, Adoue D, Sailler L, Pugnet G.

J Autoimmun. 2019 Jan;96:134-141. doi: 10.1016/j.jaut.2018.09.004. Epub 2018 Sep 17.

PMID:
30236485
24.

Cohort profile: Thrombolysis in Ischemic Stroke Patients (TRISP): a multicentre research collaboration.

Scheitz JF, Gensicke H, Zinkstok SM, Curtze S, Arnold M, Hametner C, Pezzini A, Turc G, Zini A, Padjen V, Wegener S, Nordanstig A, Kellert L, Kägi G, Bejot Y, Michel P, Leys D, Nolte CH, Nederkoorn PJ, Engelter ST; TRISP collaboration.

BMJ Open. 2018 Sep 17;8(9):e023265. doi: 10.1136/bmjopen-2018-023265.

25.

Admission in Neurorehabilitation and Association with Functional Outcomes after Stroke in France: A Nation-Wide Study, 2010-2014.

Gabet A, de Peretti C, Woimant F, Giroud M, Béjot Y, Schnitzler A, Olié V.

J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3443-3450. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.005. Epub 2018 Sep 3.

PMID:
30190227
26.

Clinical features of pain in amyotrophic lateral sclerosis: A clinical challenge.

Delpont B, Beauvais K, Jacquin-Piques A, Alavoine V, Rault P, Blanc-Labarre C, Osseby GV, Hervieu-Bègue M, Giroud M, Béjot Y.

Rev Neurol (Paris). 2019 Jan - Feb;175(1-2):11-15. doi: 10.1016/j.neurol.2017.11.009. Epub 2018 Aug 18. Review.

PMID:
30131172
27.

Determinants and outcome of multiple and early recurrent cervical artery dissections.

Compter A, Schilling S, Vaineau CJ, Goeggel-Simonetti B, Metso TM, Southerland A, Pezzini A, Kloss M, Touzé E, Worrall BB, Thijs V, Bejot Y, Reiner P, Grond-Ginsbach C, Bersano A, Brandt T, Caso V, Lyrer PA, Traenka C, Lichy C, Martin JJ, Leys D, Sarikaya H, Baumgartner RW, Jung S, Fischer U, Engelter ST, Dallongeville J, Chabriat H, Tatlisumak T, Bousser MG, Arnold M, Debette S; CADISP-plus Consortium.

Neurology. 2018 Aug 21;91(8):e769-e780. doi: 10.1212/WNL.0000000000006037. Epub 2018 Aug 1.

PMID:
30068628
28.

Pain after stroke: A review.

Delpont B, Blanc C, Osseby GV, Hervieu-Bègue M, Giroud M, Béjot Y.

Rev Neurol (Paris). 2018 Dec;174(10):671-674. doi: 10.1016/j.neurol.2017.11.011. Epub 2018 Jul 24. Review.

PMID:
30054011
29.

Increasing early ambulation disability in spontaneous intracerebral hemorrhage survivors.

Béjot Y, Blanc C, Delpont B, Thouant P, Chazalon C, Daumas A, Osseby GV, Hervieu-Bègue M, Ricolfi F, Giroud M, Cordonnier C.

Neurology. 2018 Jun 5;90(23):e2017-e2024. doi: 10.1212/WNL.0000000000005633. Epub 2018 May 4.

PMID:
29728525
30.

Associated arterial and venous cerebral manifestations in Behçet's disease.

Brenière C, Blanc C, Devilliers H, Samson M, Delpont B, Bielefeld P, Besancenot JF, Giroud M, Béjot Y.

Rev Neurol (Paris). 2018 May;174(5):337-341. doi: 10.1016/j.neurol.2017.06.031. Epub 2018 Apr 26. French.

PMID:
29704959
31.

Factors contributing to sex differences in functional outcomes and participation after stroke.

Phan HT, Blizzard CL, Reeves MJ, Thrift AG, Cadilhac DA, Sturm J, Heeley E, Otahal P, Vemmos K, Anderson C, Parmar P, Krishnamurthi R, Barker-Collo S, Feigin V, Bejot Y, Cabral NL, Carolei A, Sacco S, Chausson N, Olindo S, Rothwell P, Silva C, Correia M, Magalhães R, Appelros P, Kõrv J, Vibo R, Minelli C, Gall SL.

Neurology. 2018 May 29;90(22):e1945-e1953. doi: 10.1212/WNL.0000000000005602. Epub 2018 Apr 27.

PMID:
29703773
32.

A review of epidemiological research on stroke and dementia and exposure to air pollution.

Béjot Y, Reis J, Giroud M, Feigin V.

Int J Stroke. 2018 Oct;13(7):687-695. doi: 10.1177/1747493018772800. Epub 2018 Apr 27. Review.

PMID:
29699457
33.

Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke.

Gilliot S, Sibon I, Mas JL, Moulin T, Béjot Y, Cordonnier C, Giroud M, Odou P, Bordet R, Vivien D, Leys D; OPHELIE Investigators.

J Neurol. 2018 May;265(5):1166-1173. doi: 10.1007/s00415-018-8827-6. Epub 2018 Mar 16.

PMID:
29549467
34.

Moya-Moya syndrome after cranial radiation for optic glioma with NF1. Case report and literature review of syndromic cases.

Brandicourt P, Bonnet L, Béjot Y, Drouet C, Moulin T, Thines L.

Neurochirurgie. 2018 Mar;64(1):63-67. doi: 10.1016/j.neuchi.2017.11.004. Epub 2018 Feb 21. Review.

PMID:
29475609
35.

Controlled Education of patients after Stroke (CEOPS)- nurse-led multimodal and long-term interventional program involving a patient's caregiver to optimize secondary prevention of stroke: study protocol for a randomized controlled trial.

Mendyk AM, Duhamel A, Bejot Y, Leys D, Derex L, Dereeper O, Detante O, Garcia PY, Godefroy O, Montoro FM, Neau JP, Richard S, Rosolacci T, Sibon I, Sablot D, Timsit S, Zuber M, Cordonnier C, Bordet R; on the behalf of Strokavenir network.

Trials. 2018 Feb 22;19(1):137. doi: 10.1186/s13063-018-2483-0.

36.

Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review.

Bertoletti L, Benhamou Y, Béjot Y, Marechaux S, Cheggour S, Aleil B, Lellouche N, Dillinger JG, Delluc A.

Blood Rev. 2018 Jul;32(4):272-279. doi: 10.1016/j.blre.2018.01.002. Epub 2018 Apr 20. Review.

PMID:
29402471
37.

French validation of the Stroke Specific Quality of Life Scale (SS-QoL).

Legris N, Devilliers H, Daumas A, Carnet D, Charpy JP, Bastable P, Giroud M, Béjot Y.

NeuroRehabilitation. 2018;42(1):17-27. doi: 10.3233/NRE-172178.

PMID:
29400672
38.

Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.

Seiffge DJ, Kägi G, Michel P, Fischer U, Béjot Y, Wegener S, Zedde M, Turc G, Cordonnier C, Sandor PS, Rodier G, Zini A, Cappellari M, Schädelin S, Polymeris AA, Werring D, Thilemann S, Maestrini I, Berge E, Traenka C, Vehoff J, De Marchis GM, Kapauer M, Peters N, Sirimarco G, Bonati LH, Arnold M, Lyrer PA, De Maistre E, Luft A, Tsakiris DA, Engelter ST; Novel Oral Anticoagulants in Stroke Patients study group.

Ann Neurol. 2018 Mar;83(3):451-459. doi: 10.1002/ana.25165. Epub 2018 Mar 3.

PMID:
29394504
39.

Increasing Burden of Stroke: The Dijon Stroke Registry (1987-2012).

Guéniat J, Brenière C, Graber M, Garnier L, Mohr S, Giroud M, Delpont B, Blanc-Labarre C, Durier J, Giroud M, Béjot Y.

Neuroepidemiology. 2018;50(1-2):47-56. doi: 10.1159/000486397. Epub 2018 Feb 1.

PMID:
29393231
40.

Long-Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta-Analysis.

Boulanger M, Béjot Y, Rothwell PM, Touzé E.

J Am Heart Assoc. 2018 Jan 18;7(2). pii: e007267. doi: 10.1161/JAHA.117.007267.

41.

MRI of the Optic Nerves and Chiasm in Patients With Leber Hereditary Optic Neuropathy.

Blanc C, Heran F, Habas C, Bejot Y, Sahel J, Vignal-Clermont C.

J Neuroophthalmol. 2018 Dec;38(4):434-437. doi: 10.1097/WNO.0000000000000621.

PMID:
29300239
42.

Temporal trends in the premorbid use of preventive treatments in patients with acute ischemic cerebrovascular events and a history of vascular disease: The Dijon Stroke Registry (1985-2010).

Khoumri C, Bailly H, Delpont B, Daubail B, Blanc C, Chazalon C, Durier J, Hervieu-Bègue M, Osseby GV, Rouaud O, Giroud M, Vergely C, Béjot Y.

Presse Med. 2017 Dec;46(12 Pt 1):e259-e267. doi: 10.1016/j.lpm.2017.01.025. Epub 2017 Nov 22.

PMID:
29174475
43.

Contemporary Epidemiology of Transient Ischemic Attack in Dijon, France (2013-2015).

Béjot Y, Brenière C, Graber M, Garnier L, Durier J, Blanc-Labarre C, Delpont B, Giroud M.

Neuroepidemiology. 2017;49(3-4):135-141. doi: 10.1159/000484638. Epub 2017 Nov 16.

PMID:
29145195
44.

Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.

Scheitz JF, Turc G, Kujala L, Polymeris AA, Heldner MR, Zonneveld TP, Erdur H, Curtze S, Traenka C, Brenière C, Wiest R, Rocco A, Sibolt G, Gensicke H, Endres M, Martinez-Majander N, Béjot Y, Nederkoorn PJ, Oppenheim C, Arnold M, Engelter ST, Strbian D, Nolte CH; TRISP Collaboration.

Stroke. 2017 Dec;48(12):3239-3244. doi: 10.1161/STROKEAHA.117.018377. Epub 2017 Nov 10.

PMID:
29127269
45.

Non-office-hours admission affects intravenous thrombolysis treatment times and clinical outcome.

Zonneveld TP, Curtze S, Zinkstok SM, Gensicke H, Moulin S, Scheitz JF, Seiffge DJ, Hametner C, Heldner MR, Traenka C, Erdur H, Baharoglu I, Martinez-Majander N, Pezzini A, Zini A, Padjen V, Correia PN, Strbian D, Michel P, Béjot Y, Arnold M, Leys D, Ringleb PA, Tatlisumak T, Nolte CH, Engelter ST, Nederkoorn PJ; TRISP collaborators.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):1005-1007. doi: 10.1136/jnnp-2017-316791. Epub 2017 Oct 25. No abstract available.

PMID:
29070647
46.

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients.

Dillinger JG, Aleil B, Cheggour S, Benhamou Y, Béjot Y, Marechaux S, Delluc A, Bertoletti L, Lellouche N.

Arch Cardiovasc Dis. 2018 Feb;111(2):85-94. doi: 10.1016/j.acvd.2017.04.008. Epub 2017 Oct 2. Review.

47.

Safety of Pregnancy After Cerebral Venous Thrombosis: Results of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis)-2 PREGNANCY Study.

Aguiar de Sousa D, Canhão P, Crassard I, Coutinho J, Arauz A, Conforto A, Béjot Y, Giroud M, Ferro JM; ISCVT-2-PREGNANCY Investigators.

Stroke. 2017 Nov;48(11):3130-3133. doi: 10.1161/STROKEAHA.117.018829. Epub 2017 Oct 3.

PMID:
28974635
48.

National Trends in Patients Hospitalized for Stroke and Stroke Mortality in France, 2008 to 2014.

Lecoffre C, de Peretti C, Gabet A, Grimaud O, Woimant F, Giroud M, Béjot Y, Olié V.

Stroke. 2017 Nov;48(11):2939-2945. doi: 10.1161/STROKEAHA.117.017640. Epub 2017 Sep 29.

49.

[Screening and clinical implications of silent atrial fibrillation].

Guenancia C, Garnier F, Mouhat B, Béjot Y, Maillot N, Fichot M, Fauchier L, Cottin Y.

Rev Med Interne. 2018 Jul;39(7):574-579. doi: 10.1016/j.revmed.2017.08.006. Epub 2017 Sep 21. Review. French.

PMID:
28942937
50.

Cerebral Infarct Topography and Early Outcome after Surgery for Symptomatic Carotid Stenosis: A Multicentre Study.

Kazandjian C, Settembre N, Lareyre F, Kretz B, Soudry-Faure A, Béjot Y, Malikov S, Hassen-Khodja R, Jean-Baptiste E, Steinmetz E.

Cerebrovasc Dis. 2017;44(5-6):291-296. doi: 10.1159/000479934. Epub 2017 Sep 15.

PMID:
28910807

Supplemental Content

Support Center